Yttrium Y 90 clivatuzumab tetraxetan

60239-18-1Y Interactive imageInteractive image CHEBI:61028 108701N 5538 121841 1HTE449DGZY DTXSID60208984 InChI=1S/C16H28N4O8/c21-13(22)9-17-1-2-18(10-14(23)24)5-6-20(12-16(27)28)8-7-19(4-3-17)11-15(25)26/h1-12H2,(H,21,22)(H,23,24)(H,25,26)(H,27,28)NKey: WDLRUFUQRNWCPK-UHFFFAOYSA-NNInChI=1/C16H28N4O8/c21-13(22)9-17-1-2-18(10-14(23)24)5-6-20(12-16(27)28)8-7-19(4-3-17)11-15(25)26/h1-12H2,(H,21,22)(H,23,24)(H,25,26)(H,27,28)Key: WDLRUFUQRNWCPK-UHFFFAOYAO O=C(O)CN(CC1)CCN(CC(=O)O)CCN(CC(=O)O)CCN1CC(=O)OC1CN(CCN(CCN(CCN1CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O DOTA(also known astetraxetan) is an organic compound with the formula(CH2CH2NCH2CO2H)4. The molecule consists of a central 12-membered tetraaza (i.e., containing four nitrogen atoms) ring. DOTA is used as a complexing agent, especially forlanthanideions. Its complexes have medical applications as contrast agents and cancer treatments.